Table 3.
Pain scores (NRS) on movement in the four groups
| Group Variable |
Group (P) (n = 30) |
Group (E) (n = 30) |
Group (D) (n = 30) |
Group (D/E) (n = 30) |
P value |
|---|---|---|---|---|---|
| 0 h | 5 (5-6.25) d | 5 (5-6) d | 5 (5-6) d | 5 (4.5.25) abc | 0.013 |
| After 2 h | 5 (5-6) d | 5 (4-6) d | 5 (5-6) d | 5 (4-5) abc | 0.002 |
| After 4 h | 4 (4-5) d | 4 (4-5) d | 4 (4-5) d | 4 (3-4) abc | 0.019 |
| After 6 h | 4 (3-5) d | 4 (3-5) d | 4 (4-5) d | 4 (3-4) abc | 0.007 |
| After 12 h | 4 (3-5) d | 4 (3-4) d | 4 (3-4.25) d | 3 (3-4) abc | 0.030 |
| After 24 h | 4 (3-5) d | 4 (3-4.25) d | 4 (3-4) d | 3 (2.75-4) abc | 0.059 |
| After 48 h | 3.5 (3-4) d | 3 (3-4) d | 3.5 (3-4) d | 3 (2.75-4) abc | 0.049 |
Placebo group (P), Etoricoxib (E), Duloxetine (D), Duloxetine/Etoricoxib (D/E)
Data are presented as median (interquartile range). Data were analyzed by Mann–Whitney U-test and kruksal-wallis test and P < 0.05 is considered significant. a: when compared with P group
b: when compared with E group
c: when compared with D group
d: when compared with D/E group